Nobel Laureate Sharp Speaks to Full House in Kresge Auditorium
Nobel Laureate Phillip Sharp, PhD, spoke to a full house in Kresge Auditorium Thursday afternoon, Nov. 7. The talk by Sharp, president-elect of the American Association for the Advancement of Science, was sponsored by the Fellows of the Graduate School and the Office of the President.
Before the talk, UC President Santa Ono, PhD, presented Sharp with the President's Award for Excellence for his significant contributions in research and education. Sharp won the Nobel Prize in Physiology or Medicine in 1993 for his discovery of RNA splicing in 1977.
Sharp's topic was "Convergence: Biomedical Science in the 21st Century," and he stressed that the disciplines of biology and engineering must work together to solve today's problems. In addition, universities and private organizations must work in partnership. (As he put it, "Technology walks on two feet.")
Noting that many discoveries remain to be made, Sharp said, "In the gene world, we are no farther along than Thomas Edison and the light bulb."
Sharp spoke Friday, Nov. 8, at Cincinnati Children's Hospital Medical Center on "The Synthesis and Function of Noncoding RNAs."
For those who were unable to attend Sharp's Kresge Auditorium lecture, a video link is available here.
Kresge Auditorium was filled Thursday, Nov. 7, for a speech by Nobel Laureate Phillip Sharp, PhD.
Tags
Related Stories
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.